Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

QIAGEN NV buy JPMorgan Chase & Co.

Start price
€38.51
20.12.23 / 50%
Target price
€45.68
20.12.24
Performance (%)
8.41%
Price
€40.47
29.01.24
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 8.41%. A total of €1.28 was paid as dividends for this prediction. This prediction currently runs until 20.12.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
QIAGEN NV - -
iShares Core DAX® -0.922% -1.993%
iShares Nasdaq 100 0.371% -0.868%
iShares Nikkei 225® 2.224% -5.187%
iShares S&P 500 -0.026% -0.918%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread QIAGEN NV diskutieren
Prediction Buy
Perf. (%) 8.41%
Target price 45.675
Change
Ends at 20.12.24

Qiagen (NYSE: QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for QGEN provided by MarketBeat

Stopped prediction by JPMorgan_Chase___Co_ for QIAGEN NV

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
08.02.24
€48.24
08.02.25
-
29.01.24

buy
QIAGEN NV

Start price
Target price
Perf. (%)
€36.64
17.10.23
€47.31
17.10.24
13.95%
29.01.24